Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it reliable diagnostic and prognostic marker?
- 31 December 2001
- journal article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 33 (9) , 755-761
- https://doi.org/10.1016/s1590-8658(01)80692-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristicsGut, 2000
- Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's diseaseGut, 2000
- Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroupGastroenterology, 1996
- Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseasesLiver International, 1996
- p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosisThe Lancet, 1994
- Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.Gut, 1992
- A New Type of Perinuclear Anti-Neutrophil Cytoplasmic Antibody (p-ANCA) in Active Ulcerative Colitis but not in Crohn's DiseaseImmunobiology, 1990
- Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease.BMJ, 1988
- Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.Gut, 1988
- Recurrence of Crohn's disease after primary excisional surgeryGut, 1971